Demographic characteristics, history and work status with regard to the willingness to treat with TNF-blocking drugs
| Anti-TNF indicated by the treating rheumatologist | |||
|---|---|---|---|
| Candidate (n = 595) | Non-candidate (n = 612) | p Value | |
| IBD, inflammatory bowel disease; TNF, tumour necrosis factor. | |||
| Sex (male, %) | 73.0% | 74.4% | 0.6 |
| Age (mean (SD), years) | 43 (12) | 45 (15) | 0.08 |
| History of IBD (yes, %) | 10.5% | 8.7% | 0.32 |
| Hip involvement (yes, %) | 40.0% | 25.3% | <0.001 |
| Previous treatment: sulfasalazine (yes, %) | 63.5% | 36.5% | <0.001 |
| Previous treatment: methotrexate (yes, %) | 67.8% | 32.2% | <0.001 |
| Paid job (yes, %) | 63.7% | 61.9% | 0.54 |
| Current sick leave (yes, %) | 29.1% | 16.6% | 0.001 |